Let's Combat Pain is a website designed as an open forum for patients to share experiences in a worldwide network. We encourage singles and patient groups to become active members in order to increase visibility and share experiences.
7 September 2011
The Food and Drug Administration on Dec. 28 approved a class-wide risk management program for all :immediate-release fentanyl formulations.
The TIRF REMS [transmucosal immediate-release fentanyl Risk Evaluation and Mitigation Strategy] Access program is the agency’s first class-wide REMS for opioids. It replaces the individual REMS that exists for each product in the class now.
It will likely be the model for a REMS that the agency is developing for long-acting and extended-release opioids.
read more : http://www.zangani.com/node/198967
Most Users Ever Online: 104
Currently Browsing this Page:
Tom Kelly: 1
Guest Posters: 2296